Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

What is Monogastric Digestion?

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine.

The Journal of experimental medicine·2026

Same author

RORγt<sup>+</sup> APCs require a distinct cis-regulatory element to instruct tolerance to dietary antigens.

Nature communications·2026

Same author

Epigenetics control lineage decisions during hematopoiesis of innate lymphocytes.

Cellular & molecular immunology·2026

Same author

Microbiota-mediated mechanisms of mucosal immunity across the lifespan.

Nature immunology·2025

Same author

RORγt<sup>+</sup> APCs require a distinct cis-regulatory element to instruct tolerance to dietary antigens.

Research square·2025

Same author

Identification of antigen-presenting cell-T cell interactions driving immune responses to food.

Science (New York, N.Y.)·2024

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers.

Jeremy Goc^1,2,3, Gregory F Sonnenberg^1,2,3

¹Division of Gastroenterology & Hepatology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York.

Cancer Immunology Research

|September 27, 2022

Summary

The gut microbiota significantly influences cancer immunotherapy outcomes. Harnessing these microbes may enhance immune checkpoint blockade effectiveness, especially in gastrointestinal cancers.

More Related Videos

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

Related Experiment Videos

Last Updated: Aug 27, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

Area of Science:

Immunology
Microbiology
Oncology

Background:

Immune checkpoint blockade (ICB) has transformed cancer therapy but shows limited efficacy in many patients and tumor types.
The gut microbiota, a complex community of microbes, is increasingly recognized as a key factor influencing ICB response.
Understanding the interplay between the microbiota and the immune system is crucial for improving cancer immunotherapy.

Purpose of the Study:

To summarize current knowledge on microbiota's impact on cancer immunotherapy.
To highlight the role of the immune-microbiota dialogue in gastrointestinal cancers resistant to ICB.
To propose future research directions for leveraging microbiota in cancer treatment.

Main Methods:

Literature review and synthesis of existing research on microbiota and cancer immunotherapy.
Analysis of the unique microenvironment of gastrointestinal cancers concerning immune cells and microbiota exposure.
Discussion of potential strategies for modulating the microbiota to enhance antitumor immunity.

Main Results:

The composition and function of the gut microbiota critically affect the success of ICB.
Gastrointestinal cancers present a unique context where the immune-microbiota interaction is particularly relevant due to inherent resistance to ICB.
The immune system and microbiota engage in a dialogue that shapes the antitumor immune response.

Conclusions:

The microbiota plays a pivotal role in determining the efficacy of immune checkpoint blockade in cancer.
Targeting the microbiota offers a promising avenue to enhance antitumor immunity, particularly in challenging cancers like those of the gastrointestinal tract.
Future studies should investigate microbiota-based strategies to improve cancer immunotherapy outcomes.